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Abstract
Introduction: Diabetes during pregnancy is related to enhanced fetal growth, which has been associated with 
increased breast cancer risk. Whether daughters of mothers with a diagnosis of diabetes have an increased risk of 
breast cancer is not known.
Methods: We performed a retrospective cohort study of daughters of mothers with diabetes by linkage of the 
Swedish Multigeneration, Cause-of-Death and Patient Register between 1952 and 2005. Breast cancer cases were 
ascertained by linkage with the Swedish Cancer Register between 1958 and 2005. Standardized incidence ratios (SIRs) 
of breast cancer were calculated assuming a Poisson distribution for the observed cases.
Results: We identified 291,360 daughters of mothers with a diagnosis of diabetes before or after birth between 1952 
and 2005. Among the daughters, 7,956 cases of breast cancer were diagnosed between 1964 and 2005. The total time 
of follow-up was 12,173,821 person years. The expected number of breast cancer cases was 9,204, resulting in an SIR of 
0.86 (95% CI, 0.85 to 0.88). The decrease in risk associated with maternal diabetes was stronger for premenopausal (< 55 
years of age) than postmenopausal (≥ 55 years of age) breast cancer (SIR 0.83 and 0.91, respectively). Among daughters 
of mothers with diabetes, a history of breast cancer in the mother increased the risk of breast cancer in the daughter 
(SIR 1.43, 1.32 to 1.54).
Conclusions: Daughters of mothers with a lifetime history of diabetes were at a decreased risk of breast cancer. The 
strongest negative association was found among premenopausal breast cancer.
Introduction
In 1990, Trichopoulos suggested that breast cancer risk was
influenced by the fetal environment, particularly variations
in hormone concentrations [1]. Since then, numerous stud-
ies have assessed the association of birth weight as an inte-
grative measure of prenatal nutrition and growth and
development of breast cancer. A recent review by Michels
and Xue [2] reports that the majority of studies show a pos-
itive association with an overall increased risk of 23% (95%
confidence interval (CI) 13% to 34%) for high compared
with low birth weight, and the association appears to be
restricted to premenopausal breast cancer. While early
hypotheses suspected intrauterine estrogen as a key player,
IGF-1 and IGF-2 subsequently emerged as prime candi-
dates. The diabetic environment is associated with
increased levels of glucose and insulin, which lead to accel-
erated fetal growth and increased cell proliferation and sub-
sequently a higher proportion of macrosomia (birth weight
≥ 4,500 g) and large-for-gestational-age infants [3]. Women
with diabetes mellitus have a modest but statistically
increased risk of postmenopausal breast cancer that has
been related to altered concentrations of insulin, IGF, and/
or endogenous sex hormones [4,5]. Because of the strong
link between overweight and obesity, diabetes during preg-
nancy, and increased fetal growth [6], we hypothesized that
daughters of mothers with a lifetime history of diabetes
were at an increased risk for development of breast cancer.
Materials and methods
Study population
The study base from which our study population was drawn
is the total female Swedish population from 1932 and
onwards. The unique national registration number (NRN),
assigned at birth or immigration, allowed linkage to the fol-
lowing population-based nationwide registers: the Multi-
generation Register, the Patient Register, the Cancer
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Register, the Register of Causes of Death, the Population
Register, and the Register of Population Changes (Figure
1). The linkage provided information on all incident breast
cancers in the cohort during the period 1958 to 2005, all
deaths during 1952 to 2005, dates of emigration, and infor-
mation about vital status for each individual through the
end of the follow-up period (31 December 2005). We used
the Multigeneration Register to identify women born 1932
and onwards and their mothers who were alive in 1947 (the
year of the introduction of the NRN). The exposure of inter-
est was maternal diabetes, with the index participant indi-
cated by hospitalization for diabetes or with diabetes as a
contributing cause of death. Mothers with diabetes were
identified from the Patient Register and from the Cause of
Death Register (defined according to the relevant Interna-
tional Classification of Disease (ICD) codes ICD-7: 260;
ICD-8: 250; ICD-9: 250, 648W, 648A; and ICD-10: E10-
E14, O24) between 1964 and 2006. Diagnosis of breast
cancer for mothers and daughters between 1958 and 2005,
including date of diagnosis was ascertained through the
Cancer Register. Person-time of follow-up was calculated
for each daughter from 1958 or birth until the diagnosis of
breast cancer, death, emigration, or 31 December 2005 (end
of follow-up), whichever occurred first.
The study was approved by one of the Regional Ethical
Review Boards in Stockholm, Sweden. The board did not
require the women to provide informed consent.
Statistical Analysis
As the measure of association, we used standardized inci-
dence ratios (SIRs) of breast cancer. SIRs were calculated
by dividing the observed number of breast cancers with that
expected, based on sex-, age-, and calendar period-specific
incidence rates in the general population of Sweden. Confi-
dence intervals of 95% (95% CI) were calculated assuming
a Poisson distribution for the observed number of cases [7].
The data were analyzed with SAS software (SAS Institute
Inc., Cary, NC, USA).
Results
Through linkage among the Multigeneration Register, the
Patient Register and the Cause of Death Register, we identi-
fied 291,360 daughters of mothers with a diagnosis of dia-
betes mellitus or gestational diabetes before or after birth
from 1932 onwards. Among the daughters there were 7,956
cases of breast cancer between 1958 and 2005. The total
time of follow-up was 12,173,821 person years. The
expected number of breast cancer cases was 9,204, with a
total SIR of 0.86 (95% CI, 0.85 to 0.88). The SIRs for
breast cancer by the mother's age at diagnosis of diabetes
are listed in Table 1. The lowest SIR for breast cancer was
observed among maternal age at diabetes diagnosis
between 50 to 59 years of age. The decrease in risk associ-
ated with maternal diabetes was stronger for premenopausal
(< 55 years of age) than postmenopausal (≥ 55 years of age)
breast cancer (SIR 0.83 and 0.91, respectively) (Table 2).
Among the mothers there were 14,099 cases of breast can-
cer. Among daughters of mothers with diabetes, a history of
breast cancer in the mother increased the risk of breast can-
cer in the daughter (SIR 1.43, 1.32 to 1.54) (Table 3). SIR
for breast cancer was lowest before 1980, for all calendar
periods the SIR was significantly below 1.0 (Table 4).
Discussion
In this retrospective cohort study on close to 8,000 breast
cancer cases we observed a significantly decreased risk of
breast cancer among daughters of mothers with a lifetime
history of diabetes. The strongest negative association was
found for premenopausal breast cancer, with a 17% reduc-
tion in risk. Hence the findings from our study are in con-
tradiction to our hypothesis of an elevated risk of breast
cancer among daughters of mothers with diabetes.
Previous studies have found that increased fetal growth
measured by birth weight and height is positively associ-
ated with breast cancer risk. In a meta-analysis including
studies published between 1980 and 2007, Xue et al. report
a small but significant 15% increased risk of breast cancer
for increased birthweight and an almost 30% risk increase
for high birth length [8]. The associations appeared to be
stronger for premenopausal than postmenopausal breast
cancer. There was no association between gestational age at
birth and subsequent breast cancer risk [8].
We did not have information on gestational age and birth
weight of the daughters in the study, and therefore we could
not explore whether the inverse association between mater- Figure 1 Study design.
The Swedish Multigeneration Register
identified women born 1932 and 
onwards and their mothers who were 
alive in 1947 
Mothers with a diagnosis of Diabetes 
identified from the Swedish Patient 
and Cause of Death Registers 
between 1964 and 2006
n=291,360 
Breast cancer cases identified from 
the Swedish Cancer Register 
between 1958 and 2005 
n=7,956  (daughters)
n=14,099 (mothers) 
Person-time of follow-up calculated 
for each daughter identified from birth 
until the diagnosis of breast cancer, 
death, emigration, or December 31, 
2005 (end of follow-up), whichever 
occurred first.
12,173,821 person-
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nal diabetes and breast cancer risk among the daughters was
influenced by these perinatal factors. Another limitation of
the study is that we were not able to distinguish between
type 1, type 2, and gestational diabetes among mothers.
Type 2 diabetes is by far the most common diabetes type,
and the underlying biologic mechanisms affecting maternal
glucose metabolism are similar for all types of diabetes. We
were able to identify diabetes in the mother starting in
1965. Hence, diagnosis of diabetes in the mothers could be
after the birth of the daughters being followed for breast
cancer. We do not know whether the mother had previously
been diagnosed with diabetes, in particular, prior to her
pregnancy with the daughter, or whether the hospitalization
was related to newly diagnosed diabetes; it is possible that
the mother developed diabetes after the index daughter was
born. Since diabetes develops over a considerable time
period, however, the mother is likely to have been affected
by insulin resistance and hyperinsulinemia much earlier and
thus also during her pregnancy with the daughter [9].
Fetal weight is strongly correlated with maternal weight
in early pregnancy and weight gain during pregnancy [10].
Overweight and obese mothers are more likely to give birth
to infants with a high birth weight as well as large-for-ges-
tational-age (LGA) infants [10]. Overweight and obesity
are also closely linked to gestational diabetes and type 2
diabetes later in life [6]. We postulated that diabetes would
increase the risk of breast cancer among the offspring.
Besides gestational and type 2 diabetes, overweight and
obesity are also closely linked to development of preec-
lampsia [11], and the risk increases in a dose-dependent
manner with increasing maternal body mass index (BMI)
([12]. Intrauterine exposure to preeclampsia has been asso-
ciated with a decreased risk of breast cancer among the off-
spring [13,14]. Preeclampsia is linked to placental
dysfunction and, as a consequence, fetal growth restriction.
The placenta is the primary source of pregnancy hormones,
and placental impairment may serve as an indirect marker
for placental function during pregnancy. In a study by Cohn
et al., markers for placental dysfunction such as low placen-
tal weight, small diameter, and presence of infarctions
reduced the rate of breast cancer of the mother not
explained by preeclampsia or other known breast cancer
risk factors [15]. Reduced levels of estrogen by a decreased
synthesis of the smaller placenta as well as increased andro-
Table 1: Observed and expected breast cancers among daughters by mother's age at diagnosis of diabetes
Number of breast cancer cases
Age of mother at 
diagnosis of diabetes 
(years)
Observed Expected SIR 95% CI
Up to 49 911 1072 0.85 (0.80 to 0.91)
50 to 59 353 463 0.76 (0.69 to 0.85)
60 to 69 1,458 1,685 0.87 (0.82 to 0.91)
70 to 79 2,868 3,358 0.85 (0.82 to 0.89)
80 to 89 2,366 2,626 0.90 (0.86 to 0.94)
Total 7,956 9,204 0.86 (0.85 to 0.88)
CI, confidence interval; SIR, standardized incidence ratio.
Table 2: Observed and expected breast cancers among daughters of mothers with diabetes by age at cancer diagnosis
Number of breast cancer cases
Age of daughter at 
diagnosis of breast 
cancer
Observed Expected SIR 95% CI
< 55 4,430 5,332 0.83 (0.81 to 0.86)
≥ 55 3,526 3,872 0.91 (0.88 to 0.94)
CI, confidence interval; SIR, standardized incidence ratio.Stephansson et al. Breast Cancer Research 2010, 12:R14
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gen levels due to the inverse relation between placental size
and androgen level may explain the reduction in breast can-
cer risk among women with preeclampsia [15]. Among
parous women, the risk of breast cancer increases by pla-
cental weight of the pregnancies, and the association is
strongest for premenopausal breast cancer [16]. Unfortu-
nately, neither data on birth weight or placental weight nor
on preeclampsia were available for the population in the
current study.
Previous studies suggest a modest increase in risk of
breast cancer among women with type 2 diabetes and gesta-
tional diabetes [5]. In the present study we did not have
information on diabetes among the daughters and conse-
quently we could not study its possible influence on breast
cancer. We observed that diabetes in the mother had a stron-
ger inverse association with premenopausal than postmeno-
pausal breast cancer. Overweight and obese women have a
higher incidence of postmenopausal breast cancer, whereas
an inverse association has been consistently observed
between BMI and premenopausal breast cancer [17]. In a
large prospective Nordic study by Weiderpass et al. [18], a
decreased risk of breast cancer was observed among over-
weight and obese women. Similar findings have been
reported in a US study based on the Nurses' Health Study II
[19]. The biological rationale for this decreased risk among
overweight and obese women has been attributed to an
increased proportion of anovulatory menstrual cycles
resulting in decreased estradiol and progesterone levels
[20]. However, this mechanism was not supported in the
above mentioned studies [18,19]. Apart from reduced estro-
gen levels [21], an increased concentration of androgens
and low levels of SHBG have been suggested as the biolog-
ical rationale for the association between obesity and
reduced breast cancer risk among premenopausal women.
However, a study based on the European Prospective Inves-
tigation into Cancer and Nutrition (EPIC) reported
increased risk of premenopausal breast cancer with high
levels of testosterone and androstenedione [22].
Breast cancer incidence is higher in women with high
socioeconomic status. In a recent UK study, the relative risk
of breast cancer among the most deprived women was 16
percent lower than in the least deprived [23]. Affluent
women are more likely to have their first child at a later
age, have fewer children in their lifetime, and have an
increased use of hormone replacement therapy (HRT), fac-
tors that have been associated with an increased risk of
breast cancer. Deprived women are more likely not to
attend breast cancer screening programs, which may delay
cancer diagnosis [24]. However, we observed that the low-
est risk of breast cancer was found prior to 1980, before the
breast screening program became nationwide in Sweden.
Women with low socioeconomic status have higher preva-
lence of overweight and obesity, which are strongly related
to the development of type 2 diabetes [25]. Hence, our find-
Table 3: Observed and expected breast cancers among daughters of mothers with diabetes by family history
Number of breast cancer cases
Family history of 
breast cancer
Observed Expected SIR 95% CI
Yes 696 488 1.43 (1.32 to 1.54)
No 7,260 8,716 0.83 (0.81 to 0.85)
CI, confidence interval; SIR, standardized incidence ratio.
Table 4: Observed and expected breast cancers among daughters by calendar year of cancer diagnosis
Number of breast cancer cases
Year of breast cancer 
diagnosis
Observed Expected SIR 95% CI
Until1989 1,397 1,822 0.77 (0.73 to 0.81)
1990 to 1999 3,050 3,477 0.88 (0.85 to 0.91)
2000 and onwards 3,509 3,904 0.90 (0.87 to 0.93)
CI, confidence interval; SIR, standardized incidence ratio.Stephansson et al. Breast Cancer Research 2010, 12:R14
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ings of a decreased risk of breast cancer among daughters
of mothers with diabetes may also be due to confounding
by socioeconomic status and for age at first birth, since we
were not able to adjust for these characteristics.
By comparing breast cancer incidence in daughters of
mothers with diabetes to the general population, we proba-
bly underestimate the true association because diabetes
often goes undiagnosed for several years. The prevalence of
diabetes in Sweden has not increased between 1986 and
1999, and would therefore not influence the results [26].
Only few cohorts worldwide allow the study of prenatal
exposures and cancer risk in adult life. This is the most
likely reason why the association between maternal diabe-
tes and breast cancer has not been studied to date. The
major strengths of the present study include population-
based data with almost complete information on breast can-
cer diagnosis ascertainment and the register linkage pre-
venting recall or reporting bias and selection bias. It is
likely that we have captured the most severe cases of diabe-
tes in the cohort; however, this may only strengthen the
results, as any association will most likely be identified.
Since our comparison is made with an expected number of
breast cancer cases in an age-standardized population in
Sweden, any misclassification due to diabetes not detected
will not introduce any bias. To the best of our knowledge,
no previous study has considered the possible association
between maternal diabetes and subsequent breast cancer
risk in the daughter. Further studies accounting for maternal
as well as fetal weight, preeclampsia, and age at first birth
are warranted to verify these novel findings.
Conclusions
In conclusion we found that daughters of mothers with a
lifetime history of diabetes were at a decreased risk of
breast cancer. The strongest negative association was found
among premenopausal breast cancer.
Abbreviations
BMI: body-mass index; CI: confidence interval; EPIC: European Prospective
Investigation into Cancer and Nutrition; HRT: hormone replacement therapy;
ICD: International Classification of Disease; IGF: insulin-like growth factor; LGA:
large-for-gestational-age; NRN: national registration number; SHBG: sex hor-
mone-binding globulin; SIR: standardized incidence ratio.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
OS participated in the study design and interpretation of the results and
drafted the manuscript. FG performed the statistical analyses. AE participated
in the design of the study and interpretation of the results. KM participated in
the design, interpretation of results and coordination, and helped to draft the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
This research was supported by the U.S. Department of Defense, Breast Cancer 
Research Program (W81XWH-07-1-0557 to K.B.M.).
Author Details
1Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska 
University Hospital and Institute, T2, Stockholm, SE-171 76, Sweden, 2Division 
of Obstetrics and Gynaecology, Department of Women's and Children's Health, 
Karolinska University Hospital and Institute, H2, Stockholm, SE-171 76, Sweden, 
3Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, 
Gynecology and Reproductive Biology, Brigham and Women's Hospital, 
Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA and 
4Department of Epidemiology, Harvard School of Public Health, 677 
Huntington Avenue, Boston, MA 02115, USA
References
1. Trichopoulos D: Hypothesis: does breast cancer originate in utero?  
Lancet 1990, 335:939-940.
2. Michels KB, Xue F: Role of birthweight in the etiology of breast cancer.  
Int J Cancer 2006, 119:2007-2025.
3. Sacks DA: Etiology, detection, and management of fetal macrosomia in 
pregnancies complicated by diabetes mellitus.  Clin Obstet Gynecol 
2007, 50:980-989.
4. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, 
Manson JE: Type 2 diabetes and subsequent incidence of breast cancer 
in the Nurses' Health Study.  Diabetes Care 2003, 26:1752-1758.
5. Xue F, Michels KB: Diabetes, metabolic syndrome, and breast cancer: a 
review of the current evidence.  Am J Clin Nutr 2007, 86:s823-835.
6. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, 
Valente O: Prepregnancy BMI and the risk of gestational diabetes: a 
systematic review of the literature with meta-analysis.  Obes Rev 2009, 
10:194-203.
7. Breslow NE, Day NE: Statistical methods in cancer research. Volume II--
The design and analysis of cohort studies.  IARC Sci Publ 1987:1-406.
8. Xue F, Michels KB: Intrauterine factors and risk of breast cancer: a 
systematic review and meta-analysis of current evidence.  Lancet Oncol 
2007, 8:1088-1100.
9. Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence 
of type 2 diabetes: a systematic review.  Diabetes Care 2002, 
25:1862-1868.
10. Yu CK, Teoh TG, Robinson S: Obesity in pregnancy.  BJOG 2006, 
113:1117-1125.
11. Shand AW, Bell JC, McElduff A, Morris J, Roberts CL: Outcomes of 
pregnancies in women with pre-gestational diabetes mellitus and 
gestational diabetes mellitus; a population-based study in New South 
Wales, Australia, 1998-2002.  Diabet Med 2008, 25:708-715.
12. O'Brien TE, Ray JG, Chan WS: Maternal body mass index and the risk of 
preeclampsia: a systematic overview.  Epidemiology 2003, 14:368-374.
13. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ: Evidence of 
prenatal influences on breast cancer risk.  Lancet 1992, 340:1015-1018.
14. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D: Intrauterine 
environment and breast cancer risk in women: a population-based 
study.  J Natl Cancer Inst 1997, 89:71-76.
15. Cohn BA, Cirillo PM, Christianson RE, Berg BJ van den, Siiteri PK: Placental 
characteristics and reduced risk of maternal breast cancer.  J Natl 
Cancer Inst 2001, 93:1133-1140.
16. Cnattingius S, Torrang A, Ekbom A, Granath F, Petersson G, Lambe M: 
Pregnancy characteristics and maternal risk of breast cancer.  JAMA 
2005, 294:2474-2480.
17. Brandt PA van den, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom 
AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, 
Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ: 
Pooled analysis of prospective cohort studies on height, weight, and 
breast cancer risk.  Am J Epidemiol 2000, 152:514-527.
18. Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, Adami 
HO: A prospective study of body size in different periods of life and risk 
of premenopausal breast cancer.  Cancer Epidemiol Biomarkers Prev 2004, 
13:1121-1127.
19. Michels KB, Terry KL, Willett WC: Longitudinal study on the role of body 
size in premenopausal breast cancer.  Arch Intern Med 2006, 
166:2395-2402.
Received: 18 October 2009 Revisions Requested: 10 December 2009 
Revised: 10 February 2010 Accepted: 25 February 2010 
Published: 25 February 2010
This article is available from: http://breast-cancer-research.com/content/12/1/R14 © 2010 Stephansson et al.; licensee BioMed Central Ltd.  This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Breast Cancer Research 2010, 12:R14Stephansson et al. Breast Cancer Research 2010, 12:R14
http://breast-cancer-research.com/content/12/1/R14
Page 6 of 6
20. Key TJ, Pike MC: The role of oestrogens and progestagens in the 
epidemiology and prevention of breast cancer.  Eur J Cancer Clin Oncol 
1988, 24:29-43.
21. Potischman N, Swanson CA, Siiteri P, Hoover RN: Reversal of relation 
between body mass and endogenous estrogen concentrations with 
menopausal status.  J Natl Cancer Inst 1996, 88:756-758.
22. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, 
Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-
Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, 
Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, 
Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, et al.: Serum 
sex steroids in premenopausal women and breast cancer risk within 
the European Prospective Investigation into Cancer and Nutrition 
(EPIC).  J Natl Cancer Inst 2005, 97:755-765.
23. Shack L, Jordan C, Thomson CS, Mak V, Moller H: Variation in incidence of 
breast, lung and cervical cancer and malignant melanoma of skin by 
socioeconomic group in England.  BMC Cancer 2008, 8:271.
24. Maheswaran R, Pearson T, Jordan H, Black D: Socioeconomic deprivation, 
travel distance, location of service, and uptake of breast cancer 
screening in North Derbyshire, UK.  J Epidemiol Community Health 2006, 
60:208-212.
25. Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to 
insulin resistance and type 2 diabetes.  Nature 2006, 444:840-846.
26. Eliasson M, Lindahl B, Lundberg V, Stegmayr B: No increase in the 
prevalence of known diabetes between 1986 and 1999 in subjects 25-
64 years of age in northern Sweden.  Diabet Med 2002, 19:874-880.
doi: 10.1186/bcr2481
Cite this article as: Stephansson et al., Risk of breast cancer among daugh-
ters of mothers with diabetes: a population-based cohort study Breast Cancer 
Research 2010, 12:R14